Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Breast 2

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Uracil × Gastrointestinal × Clear all
NCT01225744 2014-06-11

eSCOUT

The Christie NHS Foundation Trust

Phase 2 Completed
47 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
900 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00152243 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
500 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00378716 2010-01-11

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

NSABP Foundation Inc

Phase 3 Completed
1,608 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00464919 2009-07-07

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

National Taiwan University Hospital

Phase 2 Completed
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡